Metraipolis › archive › dc_722e4aeb604d
The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [ 18 F]… — Europe PMC PMID:41746946
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41746946
- DOI
- 10.1097/mnm.0000000000002133
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T08:01:11.933Z
- SHA-256 of the archived text
ccfb5f25d40a97dd404b5765a664e33569abe9860e4604b1f45a13022a519a59- Stable URL of this page
https://metraipolis.com/documento/dc_722e4aeb604d
How to cite
The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [ 18 F]… — Europe PMC PMID:41746946 — Europe PMC (en), https://europepmc.org/article/MED/41746946 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_722e4aeb604d (Metraipolis archive dc_722e4aeb604d, sha256 ccfb5f25d40a97dd404b5765a664e33569abe9860e4604b1f45a13022a519a59)
BibTeX
@misc{dc722e4aeb604d,
title = {The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [ 18 F]… — Europe PMC PMID:41746946},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41746946},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_722e4aeb604d; sha256 ccfb5f25d40a97dd404b5765a664e33569abe9860e4604b1f45a13022a519a59},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41746946. Agents can read the archived copy with the MCP tool read_document.